|
|
Sold Out
Book Categories |
| Preface | ||
| Acknowledgments | ||
| Contributors | ||
| Ch. 1 | Analytical Issues Affecting the Clinical Performance of Cardiac Troponin Assays | 1 |
| Ch. 2 | Prepare To Meet Your Markers: Making the Most out of Troponin I Degradation | 13 |
| Ch. 3 | Functional Sensitivity of Cardiac Troponin Assays and its Implications for Risk Stratification for Patients with Acute Coronary Syndromes | 23 |
| Ch. 4 | Report on a Survey of Analytical and Clinical Characteristics of Commercial Cardiac Troponin Assays | 31 |
| Ch. 5 | The Current Assessment of Qualitative and Quantitative Point-of-Care Testing of Cardiac Markers | 35 |
| Ch. 6 | Acute Coronary Syndromes: Pathophysiology, Clinical Presentation, and Initial Diagnostic Strategies | 47 |
| Ch. 7 | WHO Criteria: Where Do We Go from Here? | 63 |
| Ch. 8 | An Integrated Diagnostic Approach to the Patient with Chest Pain | 75 |
| Ch. 9 | The Use of Cardiac Markers for Therapeutic Decisions in Acute Coronary Syndromes | 95 |
| Ch. 10 | The Evaluation of Acute Coronary Syndrome in the Emergency Department: The Impact of Cardiac Biomarkers and ST-Segment Trend Monitoring | 105 |
| Ch. 11 | Cardiac Troponin T in Coronary Artery Disease: Where Do We Stand? | 117 |
| Ch. 12 | Creatine Kinase: A Marker for the Early Diagnosis of Acute Myocardial Infarction | 131 |
| Ch. 13 | Fatty Acid Binding Protein as a Plasma Marker for the Early Assessment of Individuals with Acute Coronary Syndromes | 139 |
| Ch. 14 | Oxidized Low-Density Lipoprotein and Malondialdehyde-Modified Low-Density Lipoprotein: Markers of Coronary Artery Disease | 159 |
| Ch. 15 | High-Sensitivity C-Reactive Protein: A Novel Inflammatory Marker for Predicting the Risk of Coronary Artery Disease | 173 |
| Ch. 16 | Nuclear Factor Kappa B: A Marker of Coronary Artery Disease Activity? | 185 |
| Ch. 17 | The Use of Troponins to Detect Cardiac Injury after Cardiac and Noncardiac Surgery | 193 |
| Ch. 18 | The Role of Cardiac Troponin Testing in Renal Disease | 203 |
| Ch. 19 | The Use of Cardiac Biomarkers for the Detection of Drug-Induced Myocardial Damage | 211 |
| Ch. 20 | The Utility of Brain Natriuretic Peptides in Patients with Heart Failure and Coronary Artery Disease | 235 |
| Index | 263 |
| Price | Condition | Delivery | Seller | Action |
| $163.15 | Digital |
| WonderClub |
Fernando Castillo
reviewed Markers In Cardiology Aha on September 21, 2020
Markers In Cardiology Aha
Lent this book to Arnold so it will be a while before I finish it.
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish List
X
This item is in your Collection
Markers In Cardiology Aha
X
This Item is in Your Inventory
Markers In Cardiology Aha
X
You must be logged in to review the productsX
X
X
Add Markers In Cardiology Aha, Diagnostic accuracy is critical for the identification and treatment of patients with potential cardiac disease. There is now an ever-increasing reliance on the measured levels of diverse proteins (i.e. markers) whose presence in varying amounts can sugge, Markers In Cardiology Aha to the inventory that you are selling on WonderClubX
X
Add Markers In Cardiology Aha, Diagnostic accuracy is critical for the identification and treatment of patients with potential cardiac disease. There is now an ever-increasing reliance on the measured levels of diverse proteins (i.e. markers) whose presence in varying amounts can sugge, Markers In Cardiology Aha to your collection on WonderClub |